Harrow Inc (HROW) Stock: Evaluating the Market Performance

Moreover, the 36-month beta value for HROW is 0.58. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for HROW is 30.06M and currently, short sellers hold a 19.70% of that float. On April 26, 2024, HROW’s average trading volume was 459.09K shares.

HROW) stock’s latest price update

Harrow Inc (NASDAQ: HROW)’s stock price has gone rise by 5.10 in comparison to its previous close of 10.00, however, the company has experienced a 0.57% increase in its stock price over the last five trading days. InvestorPlace reported 2024-03-20 that Harrow (NASDAQ: HROW ) stock is moving on Wednesday following the release of the eyecare pharmaceutical company’s earnings report for Q4 2023. The Harrow report starts with core earnings per share of -20 cents.

HROW’s Market Performance

Harrow Inc (HROW) has experienced a 0.57% rise in stock performance for the past week, with a -17.44% drop in the past month, and a 8.24% rise in the past quarter. The volatility ratio for the week is 5.48%, and the volatility levels for the past 30 days are at 5.64% for HROW. The simple moving average for the past 20 days is -13.26% for HROW’s stock, with a -19.64% simple moving average for the past 200 days.

Analysts’ Opinion of HROW

Many brokerage firms have already submitted their reports for HROW stocks, with Craig Hallum repeating the rating for HROW by listing it as a “Buy.” The predicted price for HROW in the upcoming period, according to Craig Hallum is $24 based on the research report published on April 11, 2024 of the current year 2024.

B. Riley Securities, on the other hand, stated in their research note that they expect to see HROW reach a price target of $17. The rating they have provided for HROW stocks is “Buy” according to the report published on September 08th, 2022.

B. Riley Securities gave a rating of “Buy” to HROW, setting the target price at $16 in the report published on October 14th of the previous year.

HROW Trading at -8.63% from the 50-Day Moving Average

After a stumble in the market that brought HROW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.80% of loss for the given period.

Volatility was left at 5.64%, however, over the last 30 days, the volatility rate increased by 5.48%, as shares sank -20.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.57% lower at present.

During the last 5 trading sessions, HROW rose by +0.53%, which changed the moving average for the period of 200-days by -42.69% in comparison to the 20-day moving average, which settled at $11.98. In addition, Harrow Inc saw -6.16% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HROW starting from Opaleye Management Inc., who purchase 20,000 shares at the price of $9.97 back on Apr 25 ’24. After this action, Opaleye Management Inc. now owns 3,815,000 shares of Harrow Inc, valued at $199,400 using the latest closing price.

Opaleye Management Inc., the 10% Owner of Harrow Inc, purchase 8,285 shares at $10.15 during a trade that took place back on Apr 24 ’24, which means that Opaleye Management Inc. is holding 3,795,000 shares at $84,093 based on the most recent closing price.

Stock Fundamentals for HROW

Current profitability levels for the company are sitting at:

  • -0.01 for the present operating margin
  • 0.7 for the gross margin

The net margin for Harrow Inc stands at -0.19. The total capital return value is set at -0.01. Equity return is now at value -49.84, with -10.41 for asset returns.

Based on Harrow Inc (HROW), the company’s capital structure generated 0.72 points at debt to capital in total, while cash flow to debt ratio is standing at 0.02. The debt to equity ratio resting at 2.61. The interest coverage ratio of the stock is -0.19.

Currently, EBITDA for the company is 12.92 million with net debt to EBITDA at 31.52. When we switch over and look at the enterprise to sales, we see a ratio of 3.74. The receivables turnover for the company is 3.57for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.82.

Conclusion

To wrap up, the performance of Harrow Inc (HROW) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts